NGM BIOPHARMACEUTICALS INC Contract Liability (Deferred Revenue)
NGM BIOPHARMACEUTICALS INC had Contract Liability (Deferred Revenue) of $0 as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-03-11
- 2023-12-31: Contract with Customer, Liability, Current $0.00.
- 2023-09-30: Contract with Customer, Liability, Current $107.00K.
- 2023-06-30: Contract with Customer, Liability, Current $689.00K.
- 2023-03-31: Contract with Customer, Liability, Current $376.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2023-09-30 | $107.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $689.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $376.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $366.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $6.97M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.50M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.12M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $17.77M 10-K · filed 2023-02-28 |
| 2021-09-30 | $12.29M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.96M 10-Q · filed 2021-08-05 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.59M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.07M 10-Q · filed 2020-08-12 |
| 2019-12-31 | $4.87M 10-K · filed 2021-03-15 |
| 2019-09-30 | $14.62M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $17.44M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $22.04M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $19.02M 10-K · filed 2020-03-17 |